168 related articles for article (PubMed ID: 28876959)
1. Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion.
Dash RP; Rais R; Srinivas NR
Xenobiotica; 2018 Sep; 48(9):945-957. PubMed ID: 28876959
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4'-OH-bupropion in vitro.
Sager JE; Price LS; Isoherranen N
Drug Metab Dispos; 2016 Oct; 44(10):1709-19. PubMed ID: 27495292
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
Kharasch ED; Mitchell D; Coles R
J Clin Pharmacol; 2008 Apr; 48(4):464-74. PubMed ID: 18287571
[TBL] [Abstract][Full Text] [Related]
4. Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers.
Masters AR; Gufford BT; Lu JB; Metzger IF; Jones DR; Desta Z
J Pharmacol Exp Ther; 2016 Aug; 358(2):230-8. PubMed ID: 27255113
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion.
Kharasch ED; Lenze EJ
Drug Metab Dispos; 2024 Apr; 52(5):455-466. PubMed ID: 38467432
[TBL] [Abstract][Full Text] [Related]
6. Development, validation and application of a comprehensive stereoselective LC/MS-MS assay for bupropion and oxidative, reductive, and glucuronide metabolites in human urine.
Teitelbaum AM; Flaker AM; Kharasch ED
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():239-53. PubMed ID: 27318149
[TBL] [Abstract][Full Text] [Related]
7. Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition.
Kharasch ED; Crafford A
Clin Pharmacol Ther; 2019 Jan; 105(1):142-152. PubMed ID: 29756345
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a high-throughput stereoselective LC-MS/MS assay for bupropion, hydroxybupropion, erythrohydrobupropion, and threohydrobupropion in human plasma.
Teitelbaum AM; Flaker AM; Kharasch ED
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1017-1018():101-113. PubMed ID: 26963497
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants.
Wang PF; Neiner A; Kharasch ED
Drug Metab Dispos; 2020 Jun; 48(6):438-445. PubMed ID: 32238417
[TBL] [Abstract][Full Text] [Related]
10. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
Jefferson JW; Pradko JF; Muir KT
Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy.
Fokina VM; Xu M; Rytting E; Abdel-Rahman SZ; West H; Oncken C; Clark SM; Ahmed MS; Hankins GD; Nanovskaya TN
Drug Metab Dispos; 2016 Nov; 44(11):1832-1838. PubMed ID: 27528039
[TBL] [Abstract][Full Text] [Related]
12. An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.
Reese MJ; Wurm RM; Muir KT; Generaux GT; St John-Williams L; McConn DJ
Drug Metab Dispos; 2008 Jul; 36(7):1198-201. PubMed ID: 18420781
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective analysis of hydroxybupropion and application to drug interaction studies.
Xu H; Loboz KK; Gross AS; McLachlan AJ
Chirality; 2007 Mar; 19(3):163-70. PubMed ID: 17167747
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects.
Costa R; Oliveira NG; Dinis-Oliveira RJ
Drug Metab Rev; 2019 Aug; 51(3):293-313. PubMed ID: 31124380
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective Steady-State Disposition and Bioequivalence of Brand and Generic Bupropion in Adults.
Kharasch ED; Neiner A; Kraus K; Blood J; Stevens A; Miller JP; Lenze EJ
Clin Pharmacol Ther; 2020 Nov; 108(5):1036-1048. PubMed ID: 32386065
[TBL] [Abstract][Full Text] [Related]
16. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
Kim H; Bae SK; Park SJ; Shim EJ; Kim HS; Shon JH; Liu KH; Shin JG
Br J Clin Pharmacol; 2010 Jul; 70(1):126-31. PubMed ID: 20642555
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes.
Coles R; Kharasch ED
Pharm Res; 2008 Jun; 25(6):1405-11. PubMed ID: 18219560
[TBL] [Abstract][Full Text] [Related]
18. Comparison of In Vitro Stereoselective Metabolism of Bupropion in Human, Monkey, Rat, and Mouse Liver Microsomes.
Bhattacharya C; Kirby D; Van Stipdonk M; Stratford RE
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):261-274. PubMed ID: 30298475
[TBL] [Abstract][Full Text] [Related]
19. Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers.
Hesse LM; Greenblatt DJ; von Moltke LL; Court MH
J Clin Pharmacol; 2006 May; 46(5):567-76. PubMed ID: 16638740
[TBL] [Abstract][Full Text] [Related]
20. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
